Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
September 27, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
October 3, 2023
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
All News
07•12•23
Portfolio News
SpyBiotech
SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01
20•03•23
Portfolio News
SpyBiotech
SpyBiotech Receives Grant from the Bill & Melinda Gates Foundation
14•02•23
Portfolio News
SpyBiotech
Spybiotech appoints industry veteran Eddie Gray as Chair of its Board of Directors
11•07•22
Portfolio News
SpyBiotech
SpyBiotech appoints seasoned biotech executive Mark Leuchtenberger as Chief Executive Officer
28•04•22
Portfolio News
SpyBiotech
Studies using SpyBiotech’s vaccine technology shows potential against Covid-19 and other coronaviruses
16•11•21
Portfolio News
SpyBiotech
SpyBiotech announces the appointment of Simon Jones as VP, Finance and Operations and expansion of the scientific team
08•03•21
Portfolio News
SpyBiotech
SpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific Advisor
10•02•21
Portfolio News
SpyBiotech
SpyBiotech raises $32.5 million in Series A funding and appoints Lutz B. Giebel as Chairman
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal